Actavis, previously Watson Pharmaceuticals, today announced that it will adopt a new corporate name – Allergan – following the anticipated successful completion of the acquisition of Allergan, Inc. Continue reading
Topic: Actavis
Actavis: No Apologies for Seeking Alzheimer’s Drug Profits
NEW YORK (AP) — A lawyer for the Irish manufacturer of an Alzheimer’s drug urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-doseRead More…
FDA Approves New Antibiotic Combo from Actavis
WASHINGTON (AP) — Federal health officials have approved a new antibiotic combination to treat several hard-to-treat infections. The drug from Actavis PLC contains two ingredients, cephalosporin and avibactam, designed to help fightRead More…
Actavis to Expand Manufacturing Operations in Puerto Rico
Governor Alejandro García Padilla announced an agreement by Puerto Rico Industrial Development Company (PRIDCo) with global pharmaceutical Actavis that will allow the company to develop a solid dosage manufacturing and packing facilityRead More…
Actavis to Buy Forest Labs in $25B Deal
Actavis PLC plans to buy Forest Laboratories Inc. in an approximately $25 billion cash-and-stock combination that will create a pharmaceutical company with a product portfolio that includes drugs like the Alzheimer’s diseaseRead More…